Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf vs. Prograf in Lung Transplant Patients
NCT00930241Phase 3Terminated
- Sponsor
- Hannover Medical School
- Start
- Jul 2009
- Primary completion
- Jul 2012
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tacrolimus in lung transplantation, sponsored by Hannover Medical School. Primary endpoint: Improvement of adherence at 6 months. Started Jul 2009; status: terminated.
02
Drugs
tacrolimus
03
Conditions
lung transplantation
Beyond the preview
Go deeper on NCT00930241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930241.